Sign Up to like & get
recommendations!
3
Published in 2022 at "American journal of hematology"
DOI: 10.1002/ajh.26544
Abstract: The effects of allogeneic hematopoietic stem cell transplantation (allo-HSCT) on systemic chronic active Epstein-Barr virus infection (sCAEBV) are yet to be analyzed in a large number of patients. Using the Japanese registry database, Transplant Registry…
read more here.
Keywords:
hsct systemic;
systemic chronic;
hsct;
allo hsct ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Cancer Medicine"
DOI: 10.1002/cam4.1928
Abstract: Deferasirox is an oral iron‐chelating agent having possible antileukemia and immune modulatory effects. Few reports have evaluated deferasirox in the setting of allogeneic hematopoietic stem cell transplantation (allo‐HSCT). We investigated the impact of deferasirox after…
read more here.
Keywords:
allo hsct;
graft;
effect;
stem cell ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.2865
Abstract: Clofarabine is active in refractory/relapsed acute myeloid leukemia (AML). In this phase 2 study, we treated 18‐ to 65‐year‐old AML patients refractory to first‐line 3 + 7 daunorubicin/cytarabine induction or relapsing after 3 + 7…
read more here.
Keywords:
allo hsct;
relapsed acute;
clofarabine;
refractory relapsed ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Hematological Oncology"
DOI: 10.1002/hon.3015
Abstract: Although several studies have investigated the benefits of allogeneic hematopoietic stem cell transplantation (allo‐HSCT) for patients with inv (16) acute myeloid leukemia (AML) in first complete remission (CR1) individually stratified by KIT or FMS‐like tyrosine…
read more here.
Keywords:
combination;
flt3 itd;
allo hsct;
mutation status ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Hematological Oncology"
DOI: 10.1002/hon.70081
Abstract: Relapse and refractory T‐cell acute lymphoblastic leukemia and lymphoblastic lymphoma (R/R T‐ALL/LBL) patients have poor outcomes. Chimeric antigen receptor (CAR)‐T‐cell therapy for T‐ALL/LBL has shown encouraging results in the early stages of clinical trials. Here,…
read more here.
Keywords:
cell therapy;
allo hsct;
car cell;
car ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of Medical Virology"
DOI: 10.1002/jmv.70746
Abstract: Cytomegalovirus (CMV) infection is a prevalent complication among allogeneic hematopoietic stem cell transplant (allo‐HSCT) recipients, posing significantly impact on clinical outcomes and healthcare costs. This study aims to assess the clinical and economic burden of…
read more here.
Keywords:
infection disease;
allo hsct;
cmv infection;
hsct recipients ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Molecular Carcinogenesis"
DOI: 10.1002/mc.23514
Abstract: This study aimed to investigate the relationship between anomalous DNA nucleotidylexotransferase (DNTT) activation and the mutagenesis of gene length mutations (LMs) in acute myeloid leukemia (AML), and the relevance of their prognosis in antithymocyte globulin…
read more here.
Keywords:
regimen allo;
aml;
dntt activation;
based regimen ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Annals of Hematology"
DOI: 10.1007/s00277-018-3585-1
Abstract: Cytomegalovirus (CMV) infection and primary disease relapse remain challenging problems after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We sought to assess the association between CMV infection and disease relapse after transplantation. PubMed, EMBASE, the Cochrane…
read more here.
Keywords:
relapse;
allo hsct;
cmv;
disease relapse ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Annals of Hematology"
DOI: 10.1007/s00277-025-06537-1
Abstract: Pulmonary complications are a major cause of morbidity following pediatric allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, longitudinal pulmonary function test (PFT) trajectories and early predictors of dysfunction, particularly the interplay between underlying disease, PFTs,…
read more here.
Keywords:
pulmonary function;
allo hsct;
post;
early predictors ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Medical Microbiology and Immunology"
DOI: 10.1007/s00430-017-0511-4
Abstract: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an established treatment option for several hematological diseases. However, the first year post-transplantation is often complicated by infections and graft-versus-host disease (GVHD). Improvements in immunological monitoring could reduce…
read more here.
Keywords:
allo hsct;
risk;
viremia;
transplantation ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Clinical oral investigations"
DOI: 10.1007/s00784-020-03749-9
Abstract: OBJECTIVES We aimed to compare oral and pathogenic microorganisms in bloodstream infections (BSIs) in allogeneic hematopoietic stem cell transplantation (allo-HSCT). We also investigated the relationship between BSIs and oral mucositis to identify the ratio of…
read more here.
Keywords:
allo hsct;
hsct;
microorganisms bloodstream;
bsis ... See more keywords